Skip to content

The Effectiveness of Antimicrobial Breathing System on the Presence of Multidrug-resistant Organisms

The Effectiveness of Antimicrobial Breathing System on the Presence of Multidrug-resistant Organisms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04927806
Enrollment
24
Registered
2021-06-16
Start date
2021-11-01
Completion date
2022-06-30
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Contamination

Keywords

Bacterial contamination, nosocomail infection, bacterial detection rate

Brief summary

The aim of this study is to investigates the effectiveness of antimicrobial breathing system on multidrug-resistant organisms (MDRO).

Detailed description

Background: Cross transmission via skin contact and environmental media is the main route for common outbreak of health care-associated infection which more likely to be improved or prevented by infection control program. Silver Knight uses silver ions to disrupt the normal enzymatic activities of bacteria for reducing microbial growth within, and on, the surface of the breathing systems. It functions as a safe, quick and effective catalyst to deactivate pathogenic bacteria and prevent their proliferation. However, there was no study comparing the standard ventilator circuit with Silver Knight. This study focuses on the effectiveness of antimicrobial breathing system in MDRO which including carbapenem-resistant, vancomycin-resistant and multi-drug resistant. Study Design: This is a prospective, randomized study in a single hospital in the intensive care unit. Methods: In this study, we conduct a cluster-randomized crossover, single-centre trial. There are two groups: 1. Control group: standard ventilator circuit in odd number month. 2. Experimental group: Silver Knight in even number month This study is expected to recruit 200 subjects. During this period, the ventilator circuits are all routinely used, only the tubing will not be discarded after use for specimen collection.And the MDRO on the surfaces of ventilator circuits will be analyzed and evaluated. Effect: We expect the antimicrobial breathing system could be more effectively than the standard ventilator circuit. The policy related to current ventilator circuit will be revised according to the results of this study. Key words: Antimicrobial Breathing system, ventilator circuits, multidrug-resistant organisms (MDRO)

Interventions

DEVICESilver Knight

Silver Knight breathing systems are all validated for up to seven days use, and remain active, in unopened packaging, for up to five years. Silver Knight is proven to help reduce the incidence of MRSA infection and other organisms including: * Staphyloccus epidermis * Pseudomonas aeruginosa * Klebsiella pneumoniae * Acinetobacter calcoaceticus * Escherichia coli

Sponsors

Fu Jen Catholic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

In this study, we conduct a cluster-randomized crossover, multicenter trial.There are two groups: 1. Control group: standard ventilator circuit in odd number month. 2. Experimental group: Silver Knight in even number month

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* mechanical ventilators in Medisive CareUnit (MICU)

Exclusion criteria

* Using ventilators for less than seven days

Design outcomes

Primary

MeasureTime frameDescription
bacterial contaminationone monthcomparison of the two ventilator systems

Secondary

MeasureTime frameDescription
bacterial detection rateone monthcomparison of the two ventilator systems

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026